Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes

Completed

Conditions studied: Myelodysplastic Syndromes, Hematopoietic Cell Transplant

In brief

This is a multi-center, Phase II, cross-sectional study comparing quality of life (QOL) as assessed by patient-reported outcomes (PROs) in older (≥65 years) adults vs younger (55-64 years) undergoing allogeneic hematopoietic cell transplantation (HCT) for myelodysplastic syndromes (MDS).

Key facts

Study ID

NCT03558386

Run by

Center for International Blood and Marrow Transplant Research

People needed

92

Starts

2018-07-23

Expected to finish

2019-11-15

Last updated by the study team

2020-12-02

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• In order to be eligible to participate on this study, an individual must meet all of the following criteria:
• Underwent an allogeneic HCT for MDS on the 10-CMSMDS-1 protocol
• Prior consent to research and future contact by the CIBMTR
• Ability to provide RCI BMT protocol 17-ePRO signed and dated informed consent form (ICF)
• Age ≥55 years at time of transplant
• Fluent in English or Spanish
• Greater than 6 months post-HCT

You may not qualify if…

• An individual who meets any of the following criteria will be excluded from participation on this study.
• No access to an internet browser or email account
• Within 6 months of first HCT for MDS on the 10-CMSMDS-1 protocol

Where it is running

• Stanford University — Stanford, California, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• Karmanos Cancer Institute — Detroit, Michigan, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States
• The Ohio State University — Columbus, Ohio, United States
• Froedtert Memorial Lutheran Hospital — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.